{"filings":[{"id":453237,"accession_number":"0001171843-26-003455","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2026-05-15T13:00:30+00:00","items":["5.07"],"status":"ready","headline":"United-Guardian shareholders elect all 7 directors, approve say-on-pay and auditor at annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All seven director nominees elected; Arthur M. Dresner received highest votes (2,532,497 for, 61,445 against).","Say-on-pay frequency set at 'every year' with 2,576,591 votes in favor.","Non-binding advisory vote on executive compensation approved (2,562,179 for, 115,843 against).","Ratification of Grassi & Co. as independent auditor for FY 2026 approved (3,566,216 for, 45,290 against).","Broker non-votes totaled 945,034 on director election and advisory proposals."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":90576,"accession_number":"0001171843-26-003193","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2026-05-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"United-Guardian Q1 sales rise 16% to $2.87M; EPS $0.18 vs $0.12 YoY","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $818,902 ($0.18 per share) vs $560,895 ($0.12) in Q1 2025.","Pharmaceutical sales up 24% on Renacidin demand; cosmetic ingredient sales up 21%.","Settlement income from contract manufacturer for Renacidin shutdown in 2023 boosted results.","President sees momentum from ASI resuming regular purchases and new distribution agreements."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":2872222.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":100228,"accession_number":"0001171843-26-001972","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2026-03-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"United-Guardian FY2025 net sales down 13% to $10.5M; net income falls to $2.1M ($0.46/share)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $10.5M, down 13% from $12.2M in FY2024; net income $2.1M ($0.46/share) vs $3.3M ($0.71/share) prior year.","Cosmetic ingredient sales declined due to excess inventory at distributor Ashland Specialty Ingredients and weaker China demand.","Pharmaceuticals up 15%, medical lubricants up 4% YoY; Renacidin added to two major pharmacy benefit manager formularies.","Management optimistic about new marketing agreements and distributor efforts to regain market share in coming years."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":100227,"accession_number":"0001171843-26-000508","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2026-01-29T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"United-Guardian declares $0.25/share dividend, 31st consecutive year","summary_kind":"llm","event_type":"dividend","confidence":"high","bullets":["Cash dividend of $0.25 per share, payable Feb 17, 2026 to holders of record Feb 9, 2026.","Dividend consistent with $0.25 paid last July; marks 31st consecutive year of dividends.","President cites new distribution agreements, new personal-care products, and Renacidin sales push.","Company expects sales and earnings to continue improving based on these initiatives."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":116567,"accession_number":"0001171843-25-007076","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2025-11-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"United-Guardian Q3 revenue down 26% YoY; net income falls 69% to $0.06 EPS","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 2025 revenue $2.26M vs $3.06M in Q3 2024; net income $268K vs $865K.","Nine-month revenue $7.58M (-22%); net income $1.46M (-47%); EPS $0.32 vs $0.60.","Decline driven by reduced orders from ASI for cosmetic ingredients due to tariff/geopolitical issues.","Pharmaceutical and medical sales rose 10% and 6% respectively in first nine months.","Company advancing Renacidin formulary inclusion project to boost pharmaceutical revenue."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":7583613.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":133009,"accession_number":"0001171843-25-005206","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2025-08-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"United-Guardian Q2 net sales fall 16% YoY; EPS $0.14 vs $0.21","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 net sales $2.84M, down 16% YoY from $3.39M; net income $627K ($0.14) vs $956K ($0.21).","H1 net sales $5.32M, down 20% YoY; net income $1.19M ($0.26) vs $1.88M ($0.41).","Medical lubricants +12% and pharmaceuticals +11% in H1; cosmetic sales fell due to ASI inventory overstock in Asia.","Q2 sequential improvement: sales +14% and net income +12% vs Q1 2025.","Company pursuing Renacidin formulary expansion to boost pharmaceutical sales."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":5319352.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":133008,"accession_number":"0001171843-25-004466","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2025-07-15T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"United-Guardian declares $0.25/share cash dividend; plans growth initiatives for Renacidin and personal care products","summary_kind":"llm","event_type":"dividend","confidence":"high","bullets":["Cash dividend of $0.25 per share declared; payable August 1, 2025 to stockholders of record July 25, 2025.","This is the 30th consecutive year the company has paid a dividend.","Board retained earnings to fund new growth initiatives for personal care products and a major new project for Renacidin Irrigation Solution.","No specific financial guidance or quantitative details provided for the initiatives."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":149573,"accession_number":"0001171843-25-003368","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2025-05-21T23:59:59+00:00","items":["5.02","5.05","9.01"],"status":"ready","headline":"United-Guardian appoints President Donna Vigilante to Board of Directors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Donna Vigilante, President and 20-year veteran, appointed to Board effective May 15, 2025.","Ms. Vigilante will serve until next Annual Meeting; no additional compensation for board role.","Board also amended Code of Ethics to clarify roles, update governance, remove duplicative language.","Amendments do not constitute a waiver; Code available on company website."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":149572,"accession_number":"0001171843-25-003275","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2025-05-16T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"United-Guardian stockholders elect all six director nominees and approve say-on-pay at 2025 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All six board nominees elected; Catherine Kolinski received highest vote count (2,624,230), Ken Globus lowest (2,307,185).","Advisory vote on executive compensation frequency: 'Every year' approved with 2,509,975 votes (86.2% of votes cast).","Say-on-pay advisory proposal approved with 2,568,277 votes for (45,457 against).","Ratification of Grassi & Co. as independent auditor for FY2025 approved with 3,792,222 votes for (96.9% of shares voted)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.15,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":149571,"accession_number":"0001171843-25-002955","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2025-05-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"United-Guardian Q1 sales down 24% to $2.48M; net income falls to $0.12/share","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Sales $2,481,127 vs $3,254,944 YoY; net income $560,895 ($0.12 EPS) vs $925,442 ($0.20 EPS).","Medical lubricant sales up 43%, pharmaceutical up 23%; cosmetic ingredients down 63%.","Cosmetic ingredient decline from reduced orders by Ashland Specialty Ingredients due to China inventory buildup.","Tariff announcements by U.S. government remain a concern; impact uncertain at this time."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":2481127.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":168641,"accession_number":"0001171843-25-001610","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2025-03-21T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"United-Guardian FY 2024 net sales +12% to $12.18M; EPS $0.71 vs $0.56","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $3.25M ($0.71 per share) vs $2.58M ($0.56) in FY 2023.","Cosmetics ingredients sales surged 32%; medical lubricants up 16%.","Pharmaceutical sales fell 5% due to Renacidin supply disruption into Q1 2024.","Management expects Renacidin sales to recover to prior levels in 2025.","Growth driven by increased demand from largest distributor and Chinese accounts."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":168640,"accession_number":"0001171843-25-000528","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2025-01-30T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"United-Guardian declares $0.35 per share cash dividend, payable Feb 18, 2025","summary_kind":"llm","event_type":"dividend","confidence":"high","bullets":["Board declared $0.35 per share cash dividend on Jan 27, 2025.","Payable February 18, 2025 to holders of record February 10, 2025.","Marks 30th consecutive year of dividend payments by the company.","Dividend amount unchanged from prior distribution in July 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":185754,"accession_number":"0001171843-24-006160","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2024-11-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"United-Guardian Q3 net income up to $0.19/share; nine-month sales +17%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Nine-month 2024 sales $9.7M (+17% YoY); net income $2.7M ($0.60/share) vs $1.8M ($0.40/share) in 2023.","Q3 sales steady at $3.06M; net income $865K ($0.19/share) up from $627K ($0.14/share).","Cosmetic ingredient sales surged 68% in nine months, driven by largest distributor.","Medical lubricant sales +4% over nine months; pharmaceutical sales -11% due to Renacidin supply disruption.","President expects continued recovery from Renacidin supply shutdown."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":9705262.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":202321,"accession_number":"0001171843-24-004632","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2024-08-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"United-Guardian Q2 2024 Sales Rise 28% to $3.39M, Net Income More Than Doubles to $956K","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income for Q2 2024 was $956,225 ($0.21 per share) vs. $461,094 ($0.10 per share) in Q2 2023.","Cosmetic ingredient sales surged 84% in Q2 and 115% for the first six months of 2024.","Medical lubricant sales increased 15% in Q2 and 9% for the first half of 2024.","Pharmaceutical sales rose 3% in Q2 but fell 13% for the six months due to Renacidin contract manufacturer shutdown; production resumed late March.","Six-month sales reached $6.65 million and net income was $1.88 million, up from $5.22 million and $1.22 million a year earlier."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":6645149.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":202320,"accession_number":"0001171843-24-003916","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2024-07-12T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"United-Guardian declares $0.35 dividend, 40% increase over prior quarter; payable July 31","summary_kind":"llm","event_type":"dividend","confidence":"high","bullets":["Cash dividend of $0.35 per share declared, payable July 31, 2024 to holders of record July 23, 2024.","Represents a 40% increase over the $0.25 per share dividend paid earlier in 2024 and 250% over the $0.10 paid last July.","29th consecutive year of dividend payments.","President Donna Vigilante stated the board remains committed to growth initiatives while rewarding stockholders."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":218426,"accession_number":"0001171843-24-003010","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2024-05-21T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"United-Guardian hires Denise Costrini as Marketing Director; 25+ years personal care experience","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Appointed Denise Costrini as Marketing Director effective May 21, 2024.","Costrini has over 25 years in personal care and specialty chemicals, holds a B.S. in Industrial and Operations Engineering.","Will focus on market assessment, brand positioning, new business development, and expanding international presence.","President cites fresh perspective and opportunity to grow market penetration in key markets."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":218425,"accession_number":"0001171843-24-002952","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2024-05-17T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"United-Guardian shareholders elect all six directors, approve say-on-pay at 2024 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All six director nominees elected with substantial support; Ken Globus received 2,385,320 for, 374,345 against.","Advisory vote on executive compensation approved with 2,556,806 for, 173,892 against, 35,205 abstained.","Frequency of future say-on-pay votes set to every year (2,644,983 votes for, 32,358 every 2 years).","Ratification of Grassi & Co. as independent auditor for 2024 passed with 3,607,807 for, 16,190 against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":218424,"accession_number":"0001171843-24-002760","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2024-05-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"United-Guardian Q1 2024 sales up 27% to $3.25M; net income $0.20 per share","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 2024 sales $3.25M, up 27% YoY; net income $925K ($0.20 EPS), up from $756K ($0.16 EPS) in Q1 2023.","Cosmetic ingredients sales surged 146% driven by increased purchases from largest distributor ASI.","Pharmaceutical sales fell 30% due to Renacidin production halt at contract manufacturer; production resumed late March."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":3254944.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":238341,"accession_number":"0001171843-24-001525","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2024-03-22T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"United-Guardian FY 2023 net income flat at $2.58M; net sales down 14% to $10.89M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales of $10.89M decreased 14% from $12.70M in 2022; net income $2.58M ($0.56 EPS) unchanged.","Cosmetic ingredients sales fell due to customer destocking and just-in-time ordering, led by largest distributor.","Renacidin supply disruption at end of 2023; production has now resumed through contract manufacturer.","Management sees brighter 2024 with Renacidin restocking, customer reordering, and distributor negotiations.","No guidance or dividend change mentioned in the release."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":238340,"accession_number":"0001171843-24-001119","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2024-03-01T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"United-Guardian entered into manufacturing & supply agreement with Amsino for Renacidin Irrigation","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Agreement with Amsino Healthcare (USA) effective Jan 1, 2023 for manufacture and supply of Renacidin Irrigation.","Initial term of 6 years with automatic renewal for two successive 2-year periods.","Company will supply raw materials; Amsino manufactures, tests, releases, and ships product.","Customary provisions for regulatory compliance, quality control, indemnification, confidentiality."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":238339,"accession_number":"0001171843-24-000537","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2024-02-02T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"United-Guardian increases quarterly dividend to $0.25/share from $0.10","summary_kind":"llm","event_type":"dividend","confidence":"high","bullets":["Dividend raised to $0.25 per share from $0.10 in 2023, a 150% increase.","Payable on Feb 20, 2024 to shareholders of record as of Feb 12, 2024.","29th consecutive year the company has paid a dividend.","Board will retain higher percentage of earnings to support growth, including hiring additional personnel."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":238338,"accession_number":"0001171843-24-000121","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2024-01-08T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"United-Guardian appoints Catherine Kolinski to Board effective Jan 2, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Catherine Kolinski, with 30+ years in personal care, pharma, and industrial sectors, appointed to fill Board vacancy.","She previously served as VP of North America Consumer Specialties & Global Oral Care at Ashland Inc. (2011-2019).","As non-employee director, she receives a quarterly retainer of $12,500.","No family relationships with officers/directors; no material transactions with the company.","President Donna Vigilante stated Kolinski's experience will support the company's growth plan."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":255837,"accession_number":"0001171843-23-006751","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2023-11-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"United-Guardian Q3 sales up 26% to $3.06M; EPS doubles to $0.14","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 net sales $3.06M, up 26% YoY; net income $626.8K ($0.14 EPS) vs $345.5K ($0.07) in prior year.","Cosmetic ingredient sales surged 42%, medical lubricant sales up 73%, pharmaceutical sales up 3% in Q3.","Nine-month sales $8.28M (down 17% YoY) but net income only slightly lower at $1.84M ($0.40 EPS) vs $1.89M ($0.41).","Company plans to implement marketing strategy changes in Q1 2024 to boost sales across categories.","President expressed optimism about future sales growth."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":8278141.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":255836,"accession_number":"0001171843-23-006403","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2023-10-25T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"United-Guardian warns of Renacidin supply shortage due to supplier delays","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Amsino shifted two purchase orders from Dec 2023/Jan 2024 to Feb 2 and Feb 9, 2024.","Company notified FDA on Oct 19 of potential shortage; current supply likely insufficient.","Amsino's production shutdown extended for maintenance and FDA observations.","Mitigation measures underway; no quantitative financial impact disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":255835,"accession_number":"0001171843-23-006269","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2023-10-16T23:59:59+00:00","items":["1.02"],"status":"ready","headline":"United-Guardian notifies Ashland of non-renewal of Exclusive Distributor Agreement","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Company gave written notice on Oct 10, 2023 to Ashland that it will not renew the Exclusive Distributor Agreement.","Agreement (dated July 5, 2000, amended May 5, 2010) would have auto-renewed Jan 1, 2024 for another 2 years.","No early termination penalties will be incurred by the Company.","Company plans to explore alternative marketing/distribution arrangements; may negotiate new deal with Ashland or a new partner."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":273258,"accession_number":"0001171843-23-005496","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2023-08-31T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"United-Guardian dismisses Baker Tilly, appoints Grassi as auditor effective Aug 29, 2023","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Audit committee directed the dismissal of Baker Tilly and hiring of Grassi Advisors and Accountants.","Baker Tilly's reports for FY 2022 and 2021 contained no adverse opinion or qualification.","No disagreements or reportable events occurred during Baker Tilly's tenure as defined by Regulation S-K.","Company provided Baker Tilly with a copy of this disclosure; their letter is attached as Exhibit 16.1.","No prior consultations with Grassi on accounting principles or audit matters before appointment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":273257,"accession_number":"0001171843-23-005250","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2023-08-11T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"United-Guardian Q2 sales drop 27% YoY; net income falls to $0.10 per share","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 2023 sales $2.65M vs $3.63M in Q2 2022; net income $461K ($0.10/sh) vs $633K ($0.14/sh).","Six-month 2023 sales $5.22M vs $7.52M in prior year; net income $1.22M ($0.26/sh) vs $1.54M ($0.34/sh).","Decline driven by lower cosmetic ingredient sales (Lubrajel) in China due to competition and slow post-COVID recovery.","Pharmaceutical product Renacidin sales increased 7%, partially offsetting cosmetic decline.","Management evaluating strategies to boost sales in China and other markets."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":5220623.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":273256,"accession_number":"0001171843-23-004497","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2023-07-14T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"United-Guardian declares $0.10/share mid-year dividend; retains more earnings for growth","summary_kind":"llm","event_type":"dividend","confidence":"high","bullets":["Cash dividend of $0.10/share, payable Aug 2, 2023 to holders of record July 26, 2023.","28th consecutive year of dividend payments; payout ratio lower than prior years.","Board chooses to retain higher portion of earnings to fund anticipated growth strategy.","President cites need for additional long-term capital to increase future shareholder returns."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":290165,"accession_number":"0001171843-23-004236","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K/A","filed_at":"2023-06-28T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"United-Guardian sets President Vigilante's annual salary at $210,000; profit-sharing to be determined later","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["President Donna Vigilante's annual salary set at $210,000, effective upon her appointment.","She is eligible for profit-sharing bonuses determined by the Compensation Committee in March 2024.","No written employment agreement exists between Vigilante and the company.","Salary may be reviewed for increase at the March 2024 Compensation Committee meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":290170,"accession_number":"0001171843-23-003899","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2023-06-13T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"United-Guardian appoints Donna Vigilante as President; Beatriz Blanco departs","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Beatriz Blanco ended employment as President/CEO effective June 8, 2023; also resigned as director; separation agreement to be filed.","Donna Vigilante appointed President effective June 9, 2023; 20-year company veteran, formerly VP and R&D manager.","Vigilante will continue overseeing R&D and focus on expanding naturally-derived and eco-friendly product lines.","Chairman Ken Globus expressed confidence in Vigilante's ability to grow the company with new marketing strategies."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":290169,"accession_number":"0001171843-23-003541","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2023-05-24T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"United-Guardian regains Nasdaq stockholders' equity compliance; listing continues","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Nasdaq confirmed compliance with $10M equity minimum based on Q1 2023 10-Q filed May 12.","Company had received deficiency letters for three listing standards; now one is satisfied.","Listing on Nasdaq Global Select Market continues; Nasdaq considers the matter closed.","Remains subject to other continued listing requirements; no further action required at this time."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":290168,"accession_number":"0001171843-23-003413","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2023-05-18T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"United-Guardian annual meeting results: all directors elected, say-on-pay approved","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["All six incumbent directors re-elected; highest withhold was 541K for Ken Globus.","Advisory say-on-frequency vote favors every year (2.65M votes for).","Say-on-pay advisory resolution approved: 2.61M for, 207K against.","Ratification of Baker Tilly as auditor passed with 3.73M for, 49K against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":290167,"accession_number":"0001171843-23-003200","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2023-05-11T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"United-Guardian reports Q1 net sales down 34% YoY; EPS $0.16 vs $0.20","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $2.57M, down 34% from $3.89M in Q1 2022.","Net income $756K ($0.16 per share), down 17% from $911K ($0.20).","Decline driven by lower cosmetic ingredient and medical lubricant sales; pharma and industrial products increased.","Main Lubrajel distributor saw decreased demand in China and Asia due to COVID-19 policies and destocking."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":2570324.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":290166,"accession_number":"0001171843-23-002573","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2023-04-26T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"United-Guardian faces Nasdaq delisting for MVLS, equity, and revenue non-compliance","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq deficiency letter on April 20, 2023; market value below $50M for 30 consecutive days.","Also failed Stockholders' Equity ($10M min) and Total Assets/Total Revenue ($50M min) requirements.","Has until Oct 17, 2023 to regain MVLS compliance; must submit compliance plan by June 5, 2023 for other items.","Plans to submit compliance plan; no assurance of regaining compliance; delisting and appeal process possible."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":311096,"accession_number":"0001171843-23-001744","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2023-03-17T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"United-Guardian FY 2022 net income drops 45% to $2.57M; EPS $0.56 vs $1.01","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales fell 9% to $12.7M from $13.9M; cosmetic ingredient revenue declined, securities portfolio losses increased.","Net income $2,569,512 ($0.56 diluted EPS) vs $4,658,542 ($1.01) in prior year, a 45% decrease.","Downside blamed on contract manufacturer overstocking in 2021 and China's zero-COVID policy reducing Asian demand.","Pharmaceutical and medical lubricants business remained strong in 2022; company focused on hydrogel innovation.","No forward guidance or dividend changes announced in the release."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":329720,"accession_number":"0001171843-22-007620","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2022-11-21T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"United-Guardian declares $0.31 year-end dividend payable Dec 7, 2022","summary_kind":"llm","event_type":"dividend","confidence":"high","bullets":["Cash dividend of $0.31 per share; payable December 7, 2022 to holders of record November 28, 2022.","President cites pandemic impact on sales, especially in China during Q3, but expects a profitable year.","Board concluded dividend is appropriate based on expected profitability; optimistic for 2023 due to new marketing and product development."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":329719,"accession_number":"0001171843-22-007268","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2022-11-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"United-Guardian Q3 net income drops 66% to $345K; sales down 24% YoY","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 2022 net income $345,518 ($0.07/sh) vs $1,016,506 ($0.22/sh) in Q3 2021.","Q3 net sales fell 24% to $2,417,022 from $3,179,746 a year earlier.","Nine-month net income $1,890,307 ($0.41/sh) vs $3,542,232 ($0.77/sh); sales $9,935,557 vs $10,268,592.","CEO Beatriz Blanco cited COVID lockdowns in China and overstocking after a customer switched Lubrajel formulations.","New President and CEO Beatriz Blanco assumed role; management remains optimistic for 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":9935557.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":329718,"accession_number":"0001171843-22-006727","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2022-10-25T23:59:59+00:00","items":["1.01","5.02","9.01"],"status":"ready","headline":"CEO Ken Globus retires; Beatriz Blanco appointed President and CEO effective Nov 1, 2022","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Ken Globus retires as President & CEO effective Oct 31, 2022; remains Board Chairman.","Beatriz Blanco appointed President, CEO and elected to Board, effective Nov 1, 2022.","Blanco's initial annual base salary set at $280,000; eligible for Discretionary Bonus/Profit Sharing Plan.","Globus receives $90,000 lump-sum payment and $10,000/month consulting retainer through February 2023.","Blanco brings 20+ years in personal care; was Global Business Director at Momentive Performance Materials."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":347280,"accession_number":"0001171843-22-005640","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2022-08-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"United-Guardian Q2 net income down 53% to $0.14/share; H1 sales up 6%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["H1 2022 sales $7.52M (+6% YoY); net income $1.54M ($0.34/share) vs $2.53M ($0.55/share) in H1 2021.","Q2 net income fell to $633K ($0.14/share) from $1.34M ($0.29/share); sales down slightly to $3.63M.","Profit hit by higher raw material and shipping costs and decline in marketable securities value.","Pharmaceutical product sales up 8% QoQ; non-pharmaceutical medical product sales surged 55% on China order.","Company implemented price increases in April to partially offset rising costs; optimistic on securities recovery."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":7518535.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":363717,"accession_number":"0001171843-22-004343","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2022-06-14T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"United-Guardian suspends strategic alternatives search; CEO Ken Globus to retire by year-end","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Strategic review completed; Board found no opportunities to pursue at this time, active search suspended.","CEO Ken Globus intends to retire by end of 2022; search for replacement underway.","Globus to continue as consultant after retirement; has been with company 39 years.","Board will oversee search for new CEO with experience to accelerate growth."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":363716,"accession_number":"0001171843-22-003617","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2022-05-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"United-Guardian Q1 net sales up 13% to $3.89M, net income down 23% to $0.20 EPS; declares $0.37 dividend","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $3.89M (+13% YoY); net income $911K ($0.20 diluted EPS) vs $1.18M ($0.26) in Q1 2021.","Cosmetic ingredients sales up 27% YoY; pharmaceutical sales increased, medical products decreased.","Net income decline driven by drop in marketable securities value and higher raw material & shipping costs.","Declared $0.37/share dividend payable June 1, 2022, record May 23, 2022; marks 27th consecutive year."],"consensus_eps_estimate":null,"consensus_eps_actual":0.2,"consensus_revenue_estimate":null,"consensus_revenue_actual":3892358.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":383487,"accession_number":"0001171843-22-001940","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2022-03-17T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"United-Guardian FY 2021 net income up 41%; revenue +27% to $13.9M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income of $4.66M ($1.01/share) vs $3.30M ($0.72) in 2020, a 41% increase.","Net sales rose 27% to $13.93M from $10.99M; cosmetic ingredient sales surged 61%.","Sales to China rebounded; European sales increased 42% with UK up 42%.","Medical product sales grew 6%; pharmaceutical sales remained strong through pandemic.","Management optimistic for continued growth in 2022 with new product development."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":383486,"accession_number":"0001171843-22-000447","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2022-01-25T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"United-Guardian board launches strategic review; possible sale or partnership.","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board formally reviews strategic alternatives including joint ventures, partnerships, or sale of the company.","Capstone Partners retained as financial advisor; Brownstein Hyatt Farber Schreck as legal advisor.","No timetable set; no assurance that any transaction will result from the review.","President Ken Globus cites need to maximize shareholder value and capitalize on growth opportunities."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":401301,"accession_number":"0001171843-21-008082","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2021-11-19T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"United-Guardian declares Q4 dividend of $0.65/share, up 35% from prior dividend","summary_kind":"llm","event_type":"dividend","confidence":"high","bullets":["Cash dividend of $0.65 per share declared, payable December 7, 2021 to holders of record November 29, 2021.","Dividend is a 35% increase over the $0.48 per share paid earlier in 2021 and an 81% increase over the $0.36 paid in December 2020.","Total dividends for 2021 amount to $1.13 per share, a new company record for regular dividends in any year.","President Ken Globus stated the company expects to end 2021 with significantly better financial results than 2020, citing recovery of pandemic-era sales losses and a strong fourth quarter."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":401300,"accession_number":"0001171843-21-007773","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2021-11-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"United-Guardian Q3 net income up 42% to $1.02M; sales up 36% to $3.18M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income $1,016,506 ($0.22 per share) vs $717,532 ($0.16) in Q3 2020, a 42% increase.","Net sales $3,179,746, up 36% from $2,336,360 year-over-year.","Cosmetic ingredient sales rose 187% in Q3; Ashland Asia sales surged over 300%.","Nine-month 2021 net income $3,542,232 ($0.77 per share), up 31%; sales $10,268,592, up 19%.","Management expects full-year 2021 results significantly better than 2020 despite supply chain headwinds."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":10268592.0,"consensus_period":"2021-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":420260,"accession_number":"0001171843-21-005807","cik":101295,"company_name":"UNITED GUARDIAN INC","ticker":"UG","form_type":"8-K","filed_at":"2021-08-11T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"United-Guardian Q2 sales up 24% YoY; EPS $0.29 vs $0.26","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 2021 revenue $3.66M, up 24% from $2.95M in Q2 2020; net income $1.34M ($0.29 per share) vs. $1.19M ($0.26).","H1 2021 revenue $7.09M (+13% YoY); net income $2.53M ($0.55 per share) vs. $1.98M ($0.43).","Cosmetic ingredient sales surged 68% YoY in Q2; pharmaceutical sales strong despite ending Medicaid participation.","President cautions Delta variant may impact cosmetic ingredient sales in H2 but expects pharmaceutical resilience."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":7088846.0,"consensus_period":"2021-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":32941267.00000001,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}